Aspirin, Rivaroxaban Similar After Total Hip, Knee Arthroplasty
Extended prophylaxis with aspirin no different from rivaroxaban for preventing venous thromboembolism
Anticoagulants in Seniors With A-Fib, CKD Ups Stroke, ICH Risk
Anticoagulants linked to increased risk of ischemic stroke and hemorrhage, but lower all-cause mortality
AAD: Ustekinumab Cuts Vascular Inflammation in Psoriasis
Reduction in total aortic vascular inflammation with ustekinumab versus increase with placebo
Ulipristal Achieves Amenorrhea for Symptomatic Leiomyomas
Ulipristal superior to placebo to achieve amenorrhea for bleeding due to symptomatic uterine leiomyomas
Maternal Vaccination Not Tied to Infant Hospitalization, Death
Vaccination with influenza and Tdap not linked to risk of infant hospitalization, death in first six months
Ertugliflozin Tied to Improved Glycemic Control in T2DM
Improvement in glycemic control, reduction in body weight, SBP; increase in genital mycotic infections
Hydroxychloroquine No Better Than Placebo for Hand OA
No more effective than placebo for moderate-to-severe hand pain and radiographic osteoarthritis
Long-Term Inhaled Corticosteroid Use May Raise Fracture Risk
Long-term inhaled corticosteroid use for COPD tied to small increased risk of hip, upper extremity fracture
Influenza A(H3N2) Viruses Predominate 2017-2018 Season
Vaccine effectiveness estimated at 25 percent against A(H3N2)
Anti-Heroin Vaccine Shows Promise Against Lethal Doses
TLR9 agonist in presence of alum is stable over 30 days, elicits strong anti-heroin antibody titers
